Our previous studies have reported that oncolytic adenovirus expressing decorin, a natural inhibitor of transforming growth factor β (TGFβ) signaling, produced obvious anti-tumor responses in various animal models [16–19]. The gene discussed is DCN; the disease is neoplasm.